Dr. med. Elias Koch

Department of Dermatology

Gene network-based and ensemble modeling-based selection of tumor-associated antigens with a predicted low risk of tissue damage for targeted immunotherapy (2024) Lischer C, Eberhardt M, Flamann C, Berges J, Güse E, Wessely A, Weich A, et al. Journal article Identifizierung von Biomarkern und neuen therapeutischen Zielen beim Aderhautmelanom (2024) Wessely A, Koch E, Vera J, Berking C, Heppt M Journal article Optimizing immune checkpoint blockade in metastatic uveal melanoma: exploring the association of overall survival and the occurrence of adverse events (2024) Koch E, Petzold A, Dippel E, Erdmann M, Gesierich A, Gutzmer R, Hassel JC, et al. Journal article The Current State of Systemic Therapy of Metastatic Uveal Melanoma (2024) Koch E, Heppt M, Berking C Journal article Threshold Optimization for Tumor Markers S100b and MIA in Uveal Melanoma - A Single Center Analysis (2023) Glaser N, Petzold A, Wessely A, Kaufmann M, Koch E, Knorr H, Voskens C, et al. Journal article Poor Adherence to Self-Applied Topical Drug Treatment Is a Common Source of Low Lesion Clearance in Patients with Actinic Keratosis—A Cross-Sectional Study (2023) Koch E, Steeb T, Bender-Säbelkampf S, Busch D, Feustel J, Kaufmann M, Maronna A, et al. Journal article Is tebentafusp superior to combined immune checkpoint blockade and other systemic treatments in metastatic uveal melanoma? A comparative efficacy analysis with population adjustment (2023) Petzold A, Steeb T, Wessely A, Koch E, Vera J, Berking C, Heppt M Journal article, Review article Standardized Computer-Assisted Analysis of PRAME Immunoreactivity in Dysplastic Nevi and Superficial Spreading Melanomas (2023) Koch E, Erdmann M, Berking C, Kiesewetter F, Kramer R, Schliep S, Heppt M Journal article Conventional and three-dimensional photography as a tool to map distribution patterns of in-transit melanoma metastases on the lower extremity (2023) Müller K, Berking C, Voskens C, Heppt M, Heinzerling L, Koch E, Kramer R, et al. Journal article Liver-directed treatment is associated with improved survival and increased response to immune checkpoint blockade in metastatic uveal melanoma: results from a retrospective multicenter trial (2023) Koch E, Petzold A, Wessely A, Dippel E, Eckstein M, Gesierich A, Gutzmer R, et al. Journal article